Skip to main content

Evogene Ltd.

EVGN
Exchange
Nasdaq
Industry
Agricultural Chemicals
SEC CIK
0001574565

In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Evogene Ltd. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of EVGN: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders3829−9
Shares2.45M1.61M−838.0K (−34.2%)
Value$3.18M$1.25M−$1.93M (−60.8%)

New holders (3)

Institutions that held Evogene Ltd. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to EVGN in Q2 2022
InstitutionSharesValue% of portfolio
Two Sigma Securities, LLC10,249$8.00K0.00%
Federation des caisses Desjardins du Quebec5,000$3.85K0.00%
BNP Paribas Arbitrage, SA96$740.00%

Sold out (12)

Institutions that held Evogene Ltd. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of EVGN in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Jane Street Group, LLC65,246$85.0K
Dimensional Fund Advisors LP39,044$51.0K
Virtu Financial LLC36,576$48.0K
Occudo Quantitative Strategies LP25,826$34.0K
Schonfeld Strategic Advisors LLC19,400$25.0K
Citadel Advisors LLC15,244$20.0K
Susquehanna International Group, LLP13,201$17.0K
Walleye Capital LLC11,338$15.0K
Simplex Trading, LLC5,990$7.00K
Tower Research Capital LLC (TRC)4,541$6.00K
Howe & Rusling Inc900$1.00K
Wells Fargo & Company155$0